Trials / Not Yet Recruiting
Not Yet RecruitingNCT07460284
A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants
A Mass Balance Study of 14C-RAY1225 Injection in Healthy Chinese Participants
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, single-center, single-dose study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 14C-RAY1225 | subcutaneous injection |
Timeline
- Start date
- 2026-03-15
- Primary completion
- 2026-10-14
- Completion
- 2026-10-28
- First posted
- 2026-03-10
- Last updated
- 2026-03-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07460284. Inclusion in this directory is not an endorsement.